QBE Europe SA/NV   Report issue

For profit Phase 3
Founded: London United Kingdom (2018)
Status: No NME R&D (2018)

Organization Overview

First Clinical Trial
2019
NCT04179604
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

QBE Europe SA/NV